%0 Journal Article
%K Post-kala-azar dermal leishmaniasis (PKDL)
%K Social Stigma
%K Efficacy
%K Safety
%K Elimination
%K Treatment
%B PLoS neglected tropical diseases
%D 2024
%G ENG
%N 6
%P 1-15
%R 10.1371/journal.pntd.0012242
%T A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh.
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11189210/pdf/pntd.0012242.pdf
%V 18
%1 <p>https://www.ncbi.nlm.nih.gov/pubmed/38900786</p>

%8 06/2024
%9 Article